ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Schizophrenia, Treatment-Resistant

  • Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
  • Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
  • Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
  • The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia
  • Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
  • An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms
  • Dextromethorphan as an Augmentation Agent in Treatment-resistant Schizophrenia
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group